MGB Biopharma’s anti-bacterial agent for treatment of C. difficile infections, helped by Archangels funding round, to enter Phase II clinical trials
Tag Archive
Below you'll find a list of all posts that have been tagged as “MGB Biopharma”
-
About
Spreng Thomson: Intelligent Creative Communications
Spreng Thomson is committed to Fair Work, by ensuring that our people have an effective voice, by investing in their development and by not using zero hours contracts. -
Get in touch
+44(0)141 548 5191
[email protected]The Herald Building,
155 Albion Street,
Glasgow G1 1RU, UK
© 2023 Spreng Thomson Limited.
Registered in Scotland No. 173454 -
Connect